Astrimmune
High throughput fluid-flow cell-Imaging for cancer monitoring
- Funding £95,180
- Competition Medical Imaging
- Competition Date Autumn 2014
- Local AHSN East Midlands AHSN
- Website http://astrimmune.com/
- Key Contact Fred Jacobs
- Status On Market
- Pathways Cancer
-
Technology In-vitro Diagnostics
For high throughput fluid-flow cell imaging for bladder cancer monitoring and diagnosis, Astrimmune has developed the unique capability to biochemically analyse and image individual cells en masse under high-speed flow conditions. The company will develop enabling software tools to allow application of the technique as a cheaper, non-invasive alternative to cystoscopy for the post-surgical monitoring of bladder cancer.
Comments are closed.